Introduction
============

Glaucoma, a major eye disease that causes visual blindness, is characterized by optic nerve degeneration and visual defects. Primary open-angle glaucoma (POAG), the most common type of glaucoma, is accompanied by elevated intraocular pressure (IOP \>21 mmHg) in high-tension glaucoma (HTG) or by normal IOP (≤21 mmHg) in normal-tension glaucoma (NTG). Although elevated IOP is a major risk factor for glaucoma, increased IOP is neither necessary nor sufficient to develop POAG \[[@r1]-[@r3]\]. Several years ago, an intergenic single nucleotide polymorphism (SNP), [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601), located between *CAV2* (gene ID: 858; OMIM [601048](http://www.ncbi.nlm.nih.gov/omim/?term=601048); upstream) and *CAV1* (gene ID: 857; OMIM [601047](http://www.ncbi.nlm.nih.gov/omim/?term=601047); downstream) on human chromosome 7q31.2 was identified as associated with susceptibility to POAG in a genome-wide association study (GWAS); the association was discovered in an Icelandic Caucasian population and replicated in additional European Caucasian, Australian Caucasian, and Chinese Asian populations \[[@r4]\].

Among eight subsequent replication studies using Iowa U.S. Caucasian \[[@r5]\], Afro-Caribbean \[[@r6]\], Saudi Arabian \[[@r7]\], U.S. Caucasian \[[@r8]\], Japanese Asian \[[@r9]\], African \[[@r10]\], U.S. Caucasian \[[@r11]\], and Pakistani \[[@r12]\] populations, only three studies using U.S. Caucasian and Pakistani populations successfully replicated the POAG association \[[@r8],[@r11],[@r12]\], as well as an additional meta-analysis \[[@r13]\]. In addition, the original study \[[@r4]\] and the first positive replication study \[[@r8]\] reported preferential association with susceptibility to NTG rather than to HTG.

Interestingly, the POAG risk-associated SNP alleles in the *CAV1*-*CAV2* locus were also associated with IOP elevation \[[@r14]-[@r17]\]. Furthermore, the HTG risk association was observed in the Chinese \[[@r4]\] and Pakistani \[[@r12]\] populations. Because it seemed odd that the alleles associated with IOP elevation were preferentially associated with increased susceptibility to NTG with normal IOP rather than HTG with high IOP \[[@r4],[@r8]\], these variants were examined to replicate the associations with HTG susceptibility, as well as with IOP, and *CAV1* and *CAV2* expression.

Methods
=======

Study samples
-------------

Adhering to the ARVO statement on human subjects, this study followed the tenets of the Declaration of Helsinki. A total of 1,161 unrelated Korean participants including 229 patients with HTG (men 68.6%; mean age 56.1±15.9 years) and 932 healthy controls (men 50.1%; mean age: 57.6±13.2 years) were recruited at Chungnam National University Hospital and Seoul St. Mary's Hospital under approval from the Institutional Review Board of each hospital, and each participant provided written informed consent.

In the case group, only patients diagnosed with POAG with high IOP or HTG by two glaucoma specialists (C.-S.K. and C.K.P.) at the glaucoma clinic of the two tertiary referral hospitals as previously described were included \[[@r18],[@r19]\]. Among POAG patients with (1) characteristic glaucomatous optic nerve head defect, (2) visual field defect corresponding to the optic nerve head defect, (3) retinal nerve fiber layer defect and (4) normal open angle or deep anterior chamber angle, only those with IOP of \>21 mmHg were included in this HTG case group.

All 932 controls were free of glaucoma and other eye diseases. Participants who were free of glaucoma but had a family history of glaucoma and a history of steroid treatment were excluded in the control group. Intraocular pressure was measured with a Goldman applanation tonometer for each visit, and the average of two measurements was recorded.

SNP genotyping and association tests
------------------------------------

Under the approval of the KAIST Institutional Review Board, genomic DNA was extracted from peripheral venous blood collected in Vacutainer tubes using the Gentra Puregene blood kit (Qiagen, Valencia, CA) and stored at -80°C deep freezer until genotyped using the MassARRAY hME assay (Sequenom, San Diego, CA). The call rate was 99.9% for [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) and 98.7% for [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172), and the genotype data were under Hardy--Weinberg equilibrium (p=1.00 for [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) and p=0.54 for [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172)).

SNP association with HTG susceptibility was assessed in a comparison of 229 patients with HTG and 932 controls using logistic regression analysis, with adjustment for age, gender, and recruitment site, unless described otherwise. Association was considered statistically significant when p≤α and marginal when α\<p≤0.05, with a significance level of Bonferroni correction for multiple testing of α=0.05/2=0.025, as two SNPs were tested.

SNP association of IOP levels was additionally tested among 1,095 participants using nonparametric tests suitable for the non-normal distribution of IOP shown in Appendix 1. There were no pretreatment IOP measurement records for 66 patients with HTG, although their IOP levels were still high after treatment; therefore, these samples were excluded from the IOP association tests. The Jonckheere trend and Mann--Whitney U tests were used for [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) of three genotypes and [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) of two genotypes (with no minor-allele homozygotes), respectively.

All statistical tests were performed using [PLINK v.1.07](http://pngu.mgh.harvard.edu/~purcell/plink/) or IBM SPSS Statistics v.18 (IBM Corporation, Chicago, IL). Statistical power was calculated using the [CaTS interface](http://csg.sph.umich.edu/abecasis/CaTS/index.html).

Expression quantitative trait loci analysis
-------------------------------------------

Two data sets from the GENe Expression VARiation ([Genevar](http://www.sanger.ac.uk/resources/software/genevar/)) database \[[@r20]\] were used for the cis-expression quantitative trait loci (eQTL) analysis. The *CAV1* and *CAV2* mRNA levels in adipose, skin, and the lymphoblastoid cell line (LCL) were retrieved from a data set of tissue-dependent mRNA level measurements from 856 British Caucasians by Grundberg et al. \[[@r21]\] and used to calculate standardized regression coefficient β values. To obtain Asian data, the *CAV1* and *CAV2* mRNA levels of 82 Japanese and 80 Chinese participants in the [International HapMap Project](http://hapmap.ncbi.nlm.nih.gov/) were retrieved from another data set of population-dependent mRNA level measurements in LCLs from Stranger et al. \[[@r22]\] and used to calculate Spearman's rank-order correlation coefficient ρ values.

Results
=======

HTG susceptibility association of *CAV1-CAV2* SNPs
--------------------------------------------------

A total of 1,161 case-control subjects of Korean ancestry, whose demographic characteristics are shown in [Table 1](#t1){ref-type="table"}, were recruited to this HTG association study. The [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (G\>A) SNP had been reported in the original association study \[[@r4]\] and was the first SNP genotyped for replication in this study. Another SNP [rs1052990](http://www.ncbi.nlm.nih.gov/snp/?term=rs1052990) had been reported in the second positive-association study \[[@r8]\], but the SNP's perfectly correlated (*r*^2^=1) [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) (T\>G) was the second SNP genotyped in this study. These two SNPs were tested for HTG susceptibility by comparing genotype distributions in 229 patients with HTG and 932 healthy controls ([Table 2](#t2){ref-type="table"}).

###### Characteristics of study subjects.

  **Characteristics**                **Controls**   **HTG patients**   **p**
  ---------------------------------- -------------- ------------------ ---------
  **Demographic characteristics**                                       
  Number of subjects, n              932            229                 
  Male/female, n                     467/465        157/72             \<0.001
  Age (year)                         57.6±13.2      56.1±15.9          \<0.001
  Body mass index (kg/m^2^)          23.9 (4.0)     23.4 (4.1)         0.29
  Systolic pressure (mmHg)           109.0 (11.0)   130.0 (20.0)       0.23
  Diastolic pressure (mmHg)          64.0 (6.0)     80.0 (10.0)        0.003
  **Clinical characteristics**                                          
  Intraocular pressure (mmHg)        11.5 (1.0)     27.0 (8.5)         \<0.001
  Cup-to-disc ratio                  0.40 (0.0)     0.80 (0.20)        \<0.001
  Visual field mean deviation (dB)   \-             −7.5 (12.3)         
  Visual field pattern SD (dB)       \-             5.4 (5.5)           

Data are expressed as median (interquartile range) or average ± standard deviation (SD). p Values were calculated using Mann--Whitney U test, except chi-square test for gender and Student *t* test for age. Abbreviation: HTG, high-tension glaucoma.

###### SNP association of HTG susceptibility.

  **Association tests**         [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172)   [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601)
  ----------------------------- ---------------------------------------------------------------- --------------------------------------------------------------
  Controls (BB/Bb/bb), n        586/302/31                                                       920/11/0
  Cases (BB/Bb/bb), n           129/82/17                                                        221/8/0
  Odds ratio (95% CI)           1.5 (1.1, 2.2)                                                   2.9 (1.1, 7.4)
  p                             0.0069                                                           0.026
  Conditional test p~con~^a^    0.010                                                            0.15
  IOP-adjusted test p~adj~^b^   0.40                                                             0.42

Risk association was tested using an additive genetic model for [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) T\>G but using a dominant genetic model for [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) G\>A due to the absence of minor-allele homozygote AA. The p values were calculated with adjustment for age, gender, and recruitment site. ^a^Conditional test p~con~ values were calculated with adjustment for [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) or [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) genotype as well as age, gender, and recruitment site. ^b^IOP-adjusted test p~adj~ values were calculated with adjustment for IOP as well as age, gender, and recruitment site. Abbreviations: HTG, high-tension glaucoma; SNP, single nucleotide polymorphism; B, major allele; b, minor allele; CI, confidence interval; IOP, intraocular pressure.

HTG susceptibility was significantly associated with the second SNP [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) (odds ratio \[OR\]=1.5, p=0.0069) after Bonferroni correction for multiple testing of two SNPs (α=0.025). This association was maintained after adjusted for the genotype of the other, first SNP [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (p~con~=0.010). However, the marginal HTG susceptibility association of the first SNP [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (p=0.026) disappeared when adjusted for the genotype of the second SNP [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) (p~con~=0.15). Thus, HTG susceptibility association of the *CAV1*-*CAV2* locus was found with [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) in this Korean population.

IOP association of *CAV1-CAV2* SNPs
-----------------------------------

Next, the two SNPs were examined for association with IOP. All 932 healthy controls had IOP measurements, and only 163 patients with HTG had pretreatment IOP measurements. The other 66 patients with HTG had only post-treatment IOP measurements and therefore were excluded from this analysis to exclude the confounding treatment effect on IOP.

In a total of 1,095 samples, IOP was not normally distributed (Appendix 1), and nonparametric tests were used for this analysis. IOP was associated significantly with [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (p=0.010) but marginally with [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) (p=0.043), while the HTG risk-associated alleles in both SNPs were associated with IOP elevation.

Because IOP elevation is a strong risk factor for glaucoma, we next examined whether the increased HTG susceptibility was derived from the increase in IOP ([Table 2](#t2){ref-type="table"}). After the adjustment for the IOP, the HTG association of [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) disappeared (p~adj~=0.40). Accordingly, the HTG risk-associated allele appeared to affect the IOP, which could mostly account for its effect on susceptibility to HTG.

Gene expression association of *CAV1* and *CAV2* SNPs
-----------------------------------------------------

The HTG risk-associated SNP [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) was highly correlated with 15 SNPs (*r*^2^≥0.8) in the [Korean HapMap](http://sysbio.kribb.re.kr:8080/khapmap/description/summary.jsp) population, suggesting their possible association with HTG susceptibility. Because these SNPs from [rs1018859](http://www.ncbi.nlm.nih.gov/snp/?term=rs1018859) in chromosome position 116,067,347 to [rs7801950](http://www.ncbi.nlm.nih.gov/snp/?term=rs7801950) in position 116,154,783 spanned an 87 kb region encompassing *CAV1* and *CAV2*, the possible effects on the two gene expression levels were examined using cis-eQTL analysis with two data sets from the [Genevar](http://www.sanger.ac.uk/resources/software/genevar/) database \[[@r20]\].

The *CAV1* and *CAV2* mRNA levels were associated with the two SNPs, but more strongly with the second SNP [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) than the first SNP [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) ([Table 3](#t3){ref-type="table"}). These eQTL results were unlikely to be derived from perturbed probe binding because no SNPs in the probe binding sites were in high linkage disequilibrium (LD) with either SNP. The risk allele G of [rs1758872](http://www.ncbi.nlm.nih.gov/snp/?term=rs1758872) was significantly correlated with decreased *CAV1* mRNA in adipose (β=−0.32, p=3.9×10^−23^) and skin (β=−0.22, p=3.0×10^−18^) from the Caucasian subjects, although the effect was minimal in the LCLs derived from the Caucasian subjects (β=−0.027, p=0.00013), and no association was found in the LCLs from the Chinese (p=0.33) and Japanese (p=0.92) subjects.

###### SNP association of *CAV1* and *CAV2* expression.

  **Cell type** **(ethnicity)**                                           ***n***   ***CAV1***   ***CAV2***             
  ----------------------------------------------------------------------- --------- ------------ ------------- -------- -------------
  [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) **G**                                                  
  Adipose (CEU)                                                           856       −0.32        3.9×10^−23^   −0.11    0.00027
  Skin (CEU)                                                              856       −0.22        3.0×10^−18^   −0.11    0.00014
  LCL (CEU)                                                               856       −0.027       0.00013       0.045    4.9×10^−8^
  LCL (CHB)^a^                                                            80        −0.11        0.33          0.68     2.8×10^−12^
  LCL (JPT)^a^                                                            82        0.11         0.92          0.82     9.5×10^−21^
  [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) **A^b^**                                                 
  Adipose (CEU)                                                           856       −0.28        5.8×10^−16^   −0.067   0.031
  Skin (CEU)                                                              856       −0.20        4.0×10^−13^   −0.11    0.00041
  LCL (CEU)                                                               856       −0.030       0.000085      0.0098   0.27

Standardized regression coefficient β values were calculated using the data from Grundberg et al. \[[@r21]\]. ^a^For Asian samples, Spearman\'s rank-order correlation coefficient ρ values rather than the β values were calculated using the data from Stranger et al. \[[@r22]\]. ^b^The β values for rs4236601 are consistent with those recently reported by Hysi et al. \[[@r16]\] but direction of the risk allele effect is additionally shown here. Abbreviations: eQTL, expression quantitative trait loci; CAV, caveolin; LCL, lymphoblastoid cell line; CEU, Caucasians in Europe; CHB, Chinese in Beijing; JPT, Japanese in Tokyo.

The same risk allele was also correlated with the *CAV2* mRNA level, but the direction of the effect was opposite depending on the tissue or cell line ([Table 3](#t3){ref-type="table"}). The risk allele was associated with increased *CAV2* mRNA in the LCLs derived from the Japanese (ρ=0.82, p=9.5×10^−21^), Chinese (ρ=0.68, p=2.8×10^−12^), and Caucasian (β=0.045, p=4.9×10^−8^) subjects but decreased mRNA in adipose (β=−0.11, p=0.00027) and skin (β=−0.11, p=0.00014) from the Caucasian subjects. Accordingly, the risk-associated minor alleles, G for [rs17518872](http://www.ncbi.nlm.nih.gov/snp/?term=rs1758872) and A for [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601), decrease *CAV1* and *CAV2* mRNA in adipose and skin, although in the LCLs the alleles increase *CAV2* mRNA but tend to decrease *CAV1* mRNA.

Discussion
==========

This report describes an SNP allele in the human *CAV1*-*CAV2* locus associated with not only increased susceptibility to HTG but also increased IOP. The HTG risk-associated, minor allele G of [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) was also associated with decreased *CAV1* and *CAV2* mRNA in skin and adipose. Thus, the [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) minor allele appears to increase IOP and consequently increase HTG susceptibility possibly by decreasing the expression of *CAV1*, *CAV2*, or both.

The *CAV1* and *CAV2* genes are expressed in glaucoma- and IOP-related tissues \[[@r5]\], and the respective gene products, caveolin 1 and 2, involved in the formation of caveolae, are known to negatively regulate transforming growth factor beta (TGF-β) signaling \[[@r23],[@r24]\], which has been implicated to cause IOP elevation and optic nerve degeneration \[[@r25]\]. If so, decreased expression of *CAV1* or *CAV2* would be associated with increased IOP and HTG risk. This hypothesis is consistent with our findings that the HTG risk-associated allele of [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) confers decreased expression of *CAV1* and *CAV2* in adipose and skin, although not in LCLs, according to our eQTL analyses using the [Genevar](http://www.sanger.ac.uk/resources/software/genevar/) data for the mRNA levels.

Recently, *Cav1*-knockout mice were found to have higher IOPs than age- and sex-matched control mice \[[@r26]\]. In perfusion culture of human and porcine anterior segments, however, *CAV2* knockdown rather than *CAV1* knockdown decreased the outflow rate possibly leading to IOP elevation \[[@r27]\]. Thus, downregulation of caveolin 1 or 2 in the eye's aqueous outflow pathway could enhance TGF-β signaling to increase IOP and consequently increase HTG susceptibility.

The HTG association was more evident with [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) than [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601), as association of [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) with HTG susceptibility disappeared after adjusting for [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172), possibly because the minor allele of [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) was too rare in this Korean population to provide sufficient statistical power. This hierarchy of SNP association significance was not consistent with the original GWAS results in which [rs1052990](http://www.ncbi.nlm.nih.gov/snp/?term=rs1052990) (p=1.1×10^−9^), which was perfectly correlated with [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172), showed a less significant POAG association than [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (p=5.0×10^−10^) in a Caucasian population \[[@r4]\].

However, this hierarchy was consistent with a later finding that [rs1052990](http://www.ncbi.nlm.nih.gov/snp/?term=rs1052990) (p=3.0×10^−4^) showed a more significant POAG association than [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (p=1.4×10^−3^) in another U.S. Caucasian population \[[@r8]\]. Interestingly in a recent study, [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) was the top SNP in association with susceptibility to all POAG, but [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) was the top in association with susceptibility to POAG with early paracentral visual field loss \[[@r11]\].

The statistical power of this study to detect the originally reported association of [rs1052990](http://www.ncbi.nlm.nih.gov/snp/?term=rs1052990) (OR=1.32) or the perfectly correlated, second SNP [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) was 61% with a minor allele frequency of 21% in our samples. In contrast, the power to detect the original Caucasian association of the first SNP [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) (OR=1.36) was too low (6%), possibly because the minor allele was too rare (0.8%) in Koreans compared with 28% in Caucasians. Therefore, the marginal association of [rs4236601](http://www.ncbi.nlm.nih.gov/snp/?term=rs4236601) could have been caused by insufficient statistical power.

In summary, in a Korean population, HTG susceptibility and IOP were associated with SNP [rs17588172](http://www.ncbi.nlm.nih.gov/snp/?term=rs17588172) (and presumably its perfectly correlated SNP [rs1052990](http://www.ncbi.nlm.nih.gov/snp/?term=rs1052990) as well) in the human *CAV1*-*CAV2* locus, which appeared to affect *CAV1* and *CAV2* expression. These findings suggest that changes in the expression of *CAV1*, *CAV2*, or both could affect IOP and consequently susceptibility to HTG or POAG with elevated IOP.
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